Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 103.32 Million USD | -29.38% |
| 2021 | 146.3 Million USD | -47.14% |
| 2020 | 276.76 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 95.87 Million USD | -2.94% |
| 2023 Q1 | 98.78 Million USD | -4.4% |
| 2022 FY | 103.32 Million USD | -29.38% |
| 2022 Q4 | 103.32 Million USD | -20.83% |
| 2022 Q1 | 152.87 Million USD | 4.5% |
| 2022 Q2 | 138.96 Million USD | -9.1% |
| 2022 Q3 | 130.51 Million USD | -6.08% |
| 2021 Q1 | 277.13 Million USD | 0.13% |
| 2021 FY | 146.3 Million USD | -47.14% |
| 2021 Q4 | 146.3 Million USD | -47.09% |
| 2021 Q3 | 276.52 Million USD | -0.17% |
| 2021 Q2 | 276.98 Million USD | -0.05% |
| 2020 Q4 | 276.76 Million USD | 0.0% |
| 2020 FY | 276.76 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -4472800.433% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -5176.508% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -879.003% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -18614.048% |
| Rebus Holdings, Inc. | 5000.00 USD | -2066380.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 20.649% |
| Qrons Inc. | 420.00 USD | -24600852.381% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -13307.488% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -269.754% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -21400.883% |
| Skye Bioscience, Inc. | 11.94 Million USD | -765.33% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -165.977% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -1331.128% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -135222.314% |
| SQZ Biotechnologies Company | 107.18 Million USD | 3.604% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -7115.202% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -142681.732% |
| Mesoblast Limited | 667.9 Million USD | 84.53% |
| Marizyme, Inc. | 22.01 Million USD | -369.333% |
| Genus plc | 1.02 Billion USD | 89.958% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -7506.565% |
| Pharming Group N.V. | 462.85 Million USD | 77.677% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -3018.733% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -20604.594% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -16379.107% |
| ContraFect Corporation | 20.67 Million USD | -399.657% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -26368.494% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -26935.641% |
| IMV Inc. | 31.33 Million USD | -229.753% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -2392.124% |
| MultiCell Technologies, Inc. | 126.22 USD | -81860144.018% |
| ONE Bio Corp. | 70.08 Million USD | -47.426% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -10895.553% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 19.598% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -23833.437% |
| Q BioMed Inc. | 3.51 Million USD | -2839.084% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -193.709% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -39445.769% |
| Biomind Labs Inc. | 73.81 Thousand USD | -139869.385% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 76.849% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -7031.484% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -244.242% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -3662.25% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -14929.252% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -3869.121% |
| GB Sciences, Inc. | 103.44 Thousand USD | -99785.926% |
| Alpha Cognition Inc. | 2.45 Million USD | -4113.574% |
| HST Global, Inc. | 1526.00 USD | -6770804.325% |
| CSL Limited | 38.02 Billion USD | 99.728% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -10358.244% |
| Halberd Corporation | 10.13 Thousand USD | -1019779.578% |
| Enzolytics Inc. | 361.7 Million USD | 71.434% |
| Agentix Corp. | 261.39 Thousand USD | -39428.371% |
| Resverlogix Corp. | 8.11 Million USD | -1173.247% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -5402.162% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 97.725% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -116.603% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -16053.057% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -453453.4% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1054.567% |
| AVAX Technologies, Inc. | 7.37 Million USD | -1300.594% |
| Zenith Capital Corp. | 7410.00 USD | -1394285.965% |
| Genscript Biotech Corporation | 3.38 Billion USD | 96.949% |
| Ember Therapeutics, Inc. | 184.00 USD | -56154247.826% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -32007.543% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -39432.606% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -11034.52% |
| Kadimastem Ltd | 2.3 Million USD | -4384.393% |
| Helix BioMedix, Inc. | 3.02 Million USD | -3315.572% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -96.057% |
| BioStem Technologies, Inc. | 14.56 Million USD | -609.629% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -180871.731% |
| LadRx Corporation | 2.3 Million USD | -4377.005% |
| Cell Source, Inc. | 195.17 Thousand USD | -52840.242% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -29119.183% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -29119.183% |
| NovAccess Global Inc. | 62.24 Thousand USD | -165887.662% |
| Affymax, Inc. | 7.44 Million USD | -1288.204% |
| Itoco Inc. | 1.4 Million USD | -7279.906% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -107915.096% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -97375.472% |
| Mobile Lads Corp. | 52.00 USD | -198699900.0% |
| CytoDyn Inc. | 11.13 Million USD | -827.838% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -72168.696% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -577774.72% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -26704.61% |
| SYBLEU INC | 330.46 Thousand USD | -31165.962% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -25136.553% |
| International Stem Cell Corporation | 5.39 Million USD | -1816.957% |
| Bioxytran, Inc. | 137.63 Thousand USD | -74969.385% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -588.743% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -523.222% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -130689.873% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -11849.433% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -1274.538% |
| Neutra Corp. | 2851.00 USD | -3624031.884% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -218.842% |
| PureTech Health plc | 693.97 Million USD | 85.111% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -1180.174% |
| IXICO plc | 15.84 Million USD | -552.137% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1147.573% |
| CSL Limited | 38.02 Billion USD | 99.728% |
| Cellectis S.A. | 333.99 Million USD | 69.064% |